Table 1.
Measure (ordered first to last) | Screening | Treatment session 1–3 | ||
At-home sleep monitoring | Night | Day | ||
Informed consent | · | |||
Medical examination | · | · | ||
Baseline questionnaires (ISI, ESS, HADS and PHQ-9) | · | |||
ECG | · | |||
Urinary drug and alcohol screen | · | · | ||
Pregnancy test | · | · | ||
Overnight polysomnography (clinical EEG) | · | · | ||
Actigraphy | · | |||
Sleep diary (KSD) | · | |||
Oral fluid drug screen (Securetech DrugWipe) | · | · | ||
Quantisal saliva collection | · | · | ||
Blood plasma collection | · | · | ||
Urine collection | · | · | ||
Mood (POMS) | · | · | ||
Drug effects (DEQ) | · | · | ||
Balance (posturography) | · | · | ||
Memory (FTT and WPT) | · | · | ||
KDT with EEG | · | · | ||
Sleep questionnaires (LSEQ, RCSQ and KSS) | · | |||
Simulated driving performance | · | |||
PVT | · |
DEQ, Drug Effects Questionnaire; ECG, electrocardiogram; EEG, electroencephalography; ESS, Epworth Sleepiness Scale; FTT, Finger Tapping Task; HADS, Hospital Anxiety Depression Scale; ISI, Insomnia Severity Index; KDT, Karolinska Drowsiness Test; KSD, Karolinska Sleep Diary; KSS, Karolinska Sleepiness Scale; LSEQ, Leeds Sleep Evaluation Questionnaire; PHQ-9, Patient Health Questionnaire-9; POMS, Profile of Mood States; PSG, polysomnography; PVT, Psychomotor Vigilance Task; RCSQ, Richard Campbell Sleep Questionnaire; WPT, Word Pairs Task.